Cargando…
A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice
Facioscapulohumeral muscular dystrophy (FSHD), one of the most common muscular dystrophies, is caused by an abnormal expression of the DUX4 gene in skeletal muscles, resulting in muscle weakness. In this study, we investigated MT-DUX4-ASO, a novel gapmer antisense oligonucleotide (ASO). MT-DUX4-ASO...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525656/ https://www.ncbi.nlm.nih.gov/pubmed/37760780 http://dx.doi.org/10.3390/biomedicines11092339 |
_version_ | 1785110836729085952 |
---|---|
author | Kakimoto, Tetsuhiro Ogasawara, Akira Ishikawa, Kiyoshi Kurita, Takashi Yoshida, Kumiko Harada, Shuichi Nonaka, Taeko Inoue, Yoshimi Uchida, Keiko Tateoka, Takashi Ohta, Tetsuya Kumagai, Shinji Sasaki, Takashi Aihara, Hajime |
author_facet | Kakimoto, Tetsuhiro Ogasawara, Akira Ishikawa, Kiyoshi Kurita, Takashi Yoshida, Kumiko Harada, Shuichi Nonaka, Taeko Inoue, Yoshimi Uchida, Keiko Tateoka, Takashi Ohta, Tetsuya Kumagai, Shinji Sasaki, Takashi Aihara, Hajime |
author_sort | Kakimoto, Tetsuhiro |
collection | PubMed |
description | Facioscapulohumeral muscular dystrophy (FSHD), one of the most common muscular dystrophies, is caused by an abnormal expression of the DUX4 gene in skeletal muscles, resulting in muscle weakness. In this study, we investigated MT-DUX4-ASO, a novel gapmer antisense oligonucleotide (ASO). MT-DUX4-ASO decreased the expression of DUX4 and its target genes in FSHD patient-derived myoblasts. For the first time, we demonstrated that a systemically administered ASO, even without a ligand for drug delivery, could significantly improve muscle injury and motor function in the ACTA1-MCM/FLExDUX4 (DUX4-TG) mouse model of FSHD. Tamoxifen (TMX) injection transiently induces skeletal-muscle-specific DUX4 expression in DUX4-TG mice, while the skeletal muscles of TMX-untreated DUX4-TG mice have leaky DUX4 expression in a small subset of myofibers similar to those of FSHD patients. Subcutaneous 10 mg/kg of MT-DUX4-ASO at two-week intervals significantly suppressed muscular DUX4 target gene expression, histological muscle injury, and blood muscle injury marker elevation in TMX-untreated DUX4-TG mice. Notably, MT-DUX4-ASO at 10 mg/kg every other week significantly prevented the TMX-induced declines in treadmill test running speed and muscle force in DUX4-TG mice. Thus, the systemically administered unconjugated MT-DUX4-ASO suppressed disease progression in DUX4-TG mice, extending the potential of unconjugated ASOs as a promising FSHD treatment strategy. |
format | Online Article Text |
id | pubmed-10525656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105256562023-09-28 A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice Kakimoto, Tetsuhiro Ogasawara, Akira Ishikawa, Kiyoshi Kurita, Takashi Yoshida, Kumiko Harada, Shuichi Nonaka, Taeko Inoue, Yoshimi Uchida, Keiko Tateoka, Takashi Ohta, Tetsuya Kumagai, Shinji Sasaki, Takashi Aihara, Hajime Biomedicines Article Facioscapulohumeral muscular dystrophy (FSHD), one of the most common muscular dystrophies, is caused by an abnormal expression of the DUX4 gene in skeletal muscles, resulting in muscle weakness. In this study, we investigated MT-DUX4-ASO, a novel gapmer antisense oligonucleotide (ASO). MT-DUX4-ASO decreased the expression of DUX4 and its target genes in FSHD patient-derived myoblasts. For the first time, we demonstrated that a systemically administered ASO, even without a ligand for drug delivery, could significantly improve muscle injury and motor function in the ACTA1-MCM/FLExDUX4 (DUX4-TG) mouse model of FSHD. Tamoxifen (TMX) injection transiently induces skeletal-muscle-specific DUX4 expression in DUX4-TG mice, while the skeletal muscles of TMX-untreated DUX4-TG mice have leaky DUX4 expression in a small subset of myofibers similar to those of FSHD patients. Subcutaneous 10 mg/kg of MT-DUX4-ASO at two-week intervals significantly suppressed muscular DUX4 target gene expression, histological muscle injury, and blood muscle injury marker elevation in TMX-untreated DUX4-TG mice. Notably, MT-DUX4-ASO at 10 mg/kg every other week significantly prevented the TMX-induced declines in treadmill test running speed and muscle force in DUX4-TG mice. Thus, the systemically administered unconjugated MT-DUX4-ASO suppressed disease progression in DUX4-TG mice, extending the potential of unconjugated ASOs as a promising FSHD treatment strategy. MDPI 2023-08-22 /pmc/articles/PMC10525656/ /pubmed/37760780 http://dx.doi.org/10.3390/biomedicines11092339 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kakimoto, Tetsuhiro Ogasawara, Akira Ishikawa, Kiyoshi Kurita, Takashi Yoshida, Kumiko Harada, Shuichi Nonaka, Taeko Inoue, Yoshimi Uchida, Keiko Tateoka, Takashi Ohta, Tetsuya Kumagai, Shinji Sasaki, Takashi Aihara, Hajime A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title | A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title_full | A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title_fullStr | A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title_full_unstemmed | A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title_short | A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice |
title_sort | systemically administered unconjugated antisense oligonucleotide targeting dux4 improves muscular injury and motor function in fshd model mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525656/ https://www.ncbi.nlm.nih.gov/pubmed/37760780 http://dx.doi.org/10.3390/biomedicines11092339 |
work_keys_str_mv | AT kakimototetsuhiro asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ogasawaraakira asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ishikawakiyoshi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT kuritatakashi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT yoshidakumiko asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT haradashuichi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT nonakataeko asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT inoueyoshimi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT uchidakeiko asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT tateokatakashi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ohtatetsuya asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT kumagaishinji asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT sasakitakashi asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT aiharahajime asystemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT kakimototetsuhiro systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ogasawaraakira systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ishikawakiyoshi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT kuritatakashi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT yoshidakumiko systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT haradashuichi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT nonakataeko systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT inoueyoshimi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT uchidakeiko systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT tateokatakashi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT ohtatetsuya systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT kumagaishinji systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT sasakitakashi systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice AT aiharahajime systemicallyadministeredunconjugatedantisenseoligonucleotidetargetingdux4improvesmuscularinjuryandmotorfunctioninfshdmodelmice |